An insight into the pharmacoeconomics of carbon ion radiotherapy: a systematic review
Nine studies show CIRT is cost effective in NSCLC, Adenoid cystic carcinoma, head and neck cancer, skull-based chordoma, recurrent rectal cancer, and hepatocellular carcinoma. The cost-effectiveness of CIRT is likely to improve more in real-world clinical practice due to enhanced efficacy, reduced toxicity, reduced fractionation, and cost reductions.
Authors
- Poovizhi Bharathi R (ORCID: https://orcid.org/0000-0001-8632-8864)
- Priyanka Madhav Kamath
- Athiyamaan Mariappan Senthiappan
Institutions
- Manipal Academy of Higher Education (IN)
- Kasturba Medical College, Manipal (IN)
Publication Details
- Journal
- Radiation Oncology Journal
- Published
- 2026-03-09
- DOI
- https://doi.org/10.3857/roj.2025.00696
- Primary Topic
- Radiation Therapy and Dosimetry
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Kasturba Medical College, Manipal